Cadonilimab (Pd-1/Ctla-4) in Combination with Lenvatinib in Unresectable Hepatocellular Carcinoma (uhcc): A Retrospective Real-World Study
Heliyon(2024)
关键词
Hepatocellular carcinoma,Cadonilimab,Lenvatinib,bi-specific antibody
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要